IP Library Granted Patent US 6,861,511
Granted Patent B1
US 6,861,511 · App. 08/488,180 · Granted Mar 1, 2005

Detection and quantification of neu related proteins in the biological fluids of humans

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,861,511
App. No.
08/488,180
Granted
Mar 1, 2005
Kind
B1
Abstract

This invention relates to a substantially purified p100 which is a human neu related protein having a molecular weight in the range from about 97,000 daltons to about 115,000 daltons which corresponds substantially to the extracellular domain of the human neu gene product, said protein being detectable in a biological fluid. In another embodiment this invention relates to assays for detecting this protein. Finally, this invention also concerns monoclonal antibodies which are capable of binding to p100.

Claims (9)

1. Hybridoma cell line, designated OD-3, having ATCC accession number HB 10204.

2. Hybridoma cell line, designated NB-3, having ATCC accession number HB 10205.

3. Hybridoma cell line, designated TA-1, having ATCC accession number HB 10206.

4. Monoclonal antibody produced by the hybridoma cell line of claim 1 .

5. Monoclonal antibody produced by the hybridoma cell line of claim 2 .

6. Monoclonal antibody produced by the hybridoma cell line of claim 3 .

7. An immunoreactive fragment of the monoclonal antibody of claim 4 .

8. An immunoreactive fragment of the monoclonal antibody of claim 5 .

9. An immunoreactive fragment of the monoclonal antibody of claim 6 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2008
From: BAYER CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 021411/0409 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2008
From: BAYER HEALTHCARE LLC
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 021411/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2004
From: OSI PHARMACEUTICALS, INC.
To: BAYER CORPORATION
Reel/Frame 015965/0049 →
CHANGE OF NAME Recorded Nov 9, 2004
From: ONCOGENE SCIENCE, INC.
To: OSI PHARMACEUTICALS, INC.
Reel/Frame 015965/0183 →
MERGER AND CHANGE OF NAME Recorded Aug 30, 1999
From: ONCOGENE SCIENCE, INC.
To: OSI PHARMACEUTICALS, INC.
Reel/Frame 010197/0519 →